SOMAÍ, a number one EU-GMP-certified vertically built-in Multi-Nation Operator (MCO) specialising in cannabinoid-based medicines, in collaboration with Lusófona College, the most important Portuguese personal college and the primary establishment of Grupo Lusófona, has revealed a groundbreaking peer-reviewed paper in Prescribed drugs journal titled ‘Course of Growth for GMP-Grade Full Extract Hashish Oil: In direction of Standardised Medicinal Use.’
The research validates SOMAÍ’s patent-pending course of for producing Full-Spectrum Extract Hashish Oil (FECO), providing new scientific proof that bridges pharmaceutical precision with constant, patient-friendly formulations.
Key findings from the analysis embrace:
- Standardised Full-Spectrum Composition – SOMAÍ’s technique of terpene extraction, deep-cooled ethanol extraction and purification preserves the native cannabinoid and terpene profile of the plant all through the manufacturing course of.
- Enhanced Affected person Expertise – Sensory evaluation revealed greater acceptance rankings for SOMAÍ’s purified FECO versus crude extracts or competing merchandise. Enhancements in style, coloration, and total look make these preparations extra tolerable and efficient for sufferers.
- Scientific Differentiation – The analysis exhibits that the terpene fingerprint from the flower is remarkably preserved and will be managed for reintroduction—emphasising that terpene formulation is a science, not guesswork.
“This paper underscores SOMAÍ’s scientific management within the hashish pharmaceutical trade,” mentioned Michael Sassano, Founder and Interim CEO of SOMAÍ.
“Our research demonstrates that full-spectrum hashish formulations will be scientifically structured, reproducible, and pharmaceutically exact—dispelling the misperception that full-spectrum should imply uncontrolled or inconsistent.”
“This analysis is a step ahead in establishing scientific rigor inside the medical hashish subject,” mentioned Professor Maria do Céu Costa of Lusófona College.
“Our findings present that with the correct methodology, it’s doable to protect the integrity of the plant whereas attaining consistency, security, and improved affected person acceptance. It’s a significant contribution to each science and therapeutic innovation.”
Not like unrefined crude extracts or formulations created with out standardised methodology, SOMAÍ’s method is rooted in pharmaceutical science and managed processes. This ensures a constant cannabinoid and terpene profile that meets rigorous regulatory necessities whereas enhancing each the therapeutic efficacy and affected person expertise.
Learn the complete textual content of the publication on-line at MDPI: https://www.mdpi.com/1999-4923/17/7/848
